Skip to main content

Advertisement

ADVERTISEMENT

poster

Idiopathic hypersomnia (IH) is a rare neurologic disorder characterized by excessive daytime sleepiness, sleep inertia, long and unrefreshing sleep/naps, and cognitive dysfunction. Sympho...
10/26/2023
This study used qualitative interviews to understand the patient experience of narcolepsy (types 1[NT1]=12 and 2 [NT2]=10). Many participants received a narcolepsy diagnosis at least 10 y...
10/26/2023
This poster discusses results of a survey sent to consult liason psychiatrists regarding their views on consults regarding maternal capacity to care for a newborn. Our results showed diff...
10/26/2023
The presented study evaluated the CV safety and PK after SDX, a prodrug of d-MPH, relative to Ritalin IR and Ritalin LA. At an SDX dose (200 mg) of 2.5x the molar-equivalent Ritalin doses...
10/26/2023
This study compared the odds of cardiovascular (CV) conditions in patients with idiopathic hypersomnia (IH) versus matched non-IH controls using Merative™ MarketScan® administrative claim...
10/26/2023
The benefit-risk profile of cariprazine is favorable for major depressive disorder adjunctive treatment.
10/26/2023
KarXT, a combination of xanomeline (dual M1/M4 muscarinic receptor agonist) and trospium (peripherally restricted muscarinic receptor antagonist), showed promising results in the EMERGENT...
10/26/2023
Centanafadine (CTN) is a norepinephrine/dopamine/serotonin reuptake inhibitor being investigated for the treatment of attention-deficit/hyperactivity disorder (ADHD). Secondary efficacy o...
10/26/2023
This analysis of 2 pooled, 6-week, placebo-controlled monotherapy studies; a 6-month open-label extension (OLE) monotherapy study; and a 6-week, placebo-controlled adjunctive study evalua...
10/26/2023
This retrospective cohort study utilized claims data to examine care patterns of patients newly diagnosed with major depressive disorder (MDD) in outpatient settings. The study provided v...
10/26/2023

Advertisement